Cover Image
市場調查報告書

全球非口服營養市場

Parenteral Nutrition

出版商 Global Industry Analysts, Inc. 商品編碼 210379
出版日期 內容資訊 英文 227 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球非口服營養市場 Parenteral Nutrition
出版日期: 2017年09月01日 內容資訊: 英文 227 Pages
簡介

本報告提供全球非口服營養市場的相關調查,彙整市場趨勢與2016∼2024年的預測,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 非口服營養:靜脈注射提供不可或缺的營養
    • 慢性症狀相關的營養不良加速非口服營養產品的需求
    • 未來發展預測
    • 已開發國家主導市場但發展中國家推動未來的成長
    • 單劑量氨基酸:佔市場大佔有率
    • 競爭環境
  • 市場趨勢,促進要素,課題
    • 住院期間營養不良的不可或缺的臨床營養
    • 醫療支出擴大促進市場
    • 迅速的高齡化促進需求
    • 慢性疾病的發病率上升推動市場成長
    • 癌症患者:最大用戶
    • 腸胃疾病患者不可或缺 其他
  • 產品概要
    • 靜脈注射劑:概要
    • 靜脈注射治療
    • 靜脈注射藥物
    • 靜脈注射接口設備的種類
    • 靜脈注射治療所考慮的風險
    • 非口服營養:概要
    • 給藥途徑
    • 非口服藥物的類型
    • 法規前提條件 其他
  • 產品創新/引進
  • 近幾年的產業活動
  • 全球主要企業
    • Allergan plc
    • Amanta Healthcare Ltd
    • B. Braun Melsungen AG
    • Baxter International, Inc.
    • Fresenius KABI AG (Germany)
    • Grifols International S.A.
    • ICU Medical, Inc.
    • 大塚製藥株式會社
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • Sino-Swed Pharmaceutical Corp. Ltd.
  • 全球市場預測

第3章 市場

  • 美國
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南美

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7641

This report analyzes the worldwide markets for Parenteral Nutrition in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 20 companies including many key and niche players such as -

Allergan plc
Amanta Healthcare Ltd.
B. Braun Melsungen AG
Baxter International, Inc.
Fresenius KABI AG
Grifols International S.A.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding
  • Malnutrition Related to Chronic Medical Conditions Fuels Demand for PN Products
  • The Road Ahead...
  • Developed Economies Lead, Developing Regions to Propel Future Growth
    • Table 1: Fastest Growing Regional Markets in the World Parenteral Nutrition Market: Ranked by % CAGR for the Period 2016-2024 (includes corresponding Graph/Chart)
  • Single Dose Amino Acid Solutions - Major Share of PN Solutions Market
    • Table 2: Global Parenteral Nutrition Products Market (2017E): Percentage Breakdown of Revenues by Product Category - Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements and Vitamins and Minerals (includes corresponding Graph/Chart)
  • Competitive Landscape
    • Table 3: Leading Players in the Global Parenteral Nutrition Market (2017E): Percentage Breakdown of Revenues for B. Braun, Baxter, Fresenius, ICU Medical and Others (includes corresponding Graph/Chart)

2. MARKET TRENDS, DRIVERS & ISSUES

  • Clinical Nutrition Vital for Combating Malnutrition during Hospitalization
    • Table 4: Daily Requirements for Adults (Male and Female) by Nutrient Type
    • Table 5: Energy Requirements by Age and Gender (includes corresponding Graph/Chart)
    • Table 6: Protein and Vitamin Requirements by Gender
    • Table 7: Mineral Requirements by Gender and Mineral Type
  • Increase in Healthcare Spending Bodes Well for Parenteral Nutrition Market
    • Table 8: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)
    • Table 9: Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart)
  • Rapidly Aging Demographics to Propel Demand for Parenteral Nutrition
    • Table 10: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
    • Table 11: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart)
    • Table 12: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Rising Incidence of Chronic Diseases to Propel Growth of Parenteral Nutrition Market
    • Table 13: Global Parenteral Nutrition Market (2016): Percentage Breakdown of Number of Patients by Disease Condition (includes corresponding Graph/Chart)
  • Cancer Patients - the Highest PN Users
    • Table 14: Worldwide Incidence of Cancer: Number of New Cases Diagnosed for the Years 2013, 2020 & 2030 (includes corresponding Graph/Chart)
    • Table 15: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
    • Table 16: Common Cause of Cancer Deaths Worldwide - Number of Deaths due to Select Types of Cancer for 2015 (includes corresponding Graph/Chart)
  • Parenteral Nutrition: Critical for People with Gastrointestinal Disorders
  • Unrelenting Threat of HIV/AIDS Infection: An Opportunity for Parenteral Nutrition Market
    • Persistent Threat of HIV/AIDS - A Peek at Global HIV Statistics
    • Table 17: People Living with HIV Infection (in Million) by Region for 2016 (includes corresponding Graph/Chart)
    • Table 18: New HIV Infections Worldwide by Geographic Region for 2016 (in Thousands) (includes corresponding Graph/Chart)
    • Table 19: Global AIDS-Related Deaths by Geographic Region for the Year 2016 (includes corresponding Graph/Chart)
  • Diabetes Mellitus: PN Therapy Indicated for Patients with Non-functional GI Tract
    • Global Diabetic Statistics - Opportunity Indicators
    • Table 20: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart)
    • Table 21: Global Prevalence (%) of Diabetes in Adults (20-79) by Region: 2015 & 2040 (includes corresponding Graph/Chart)
    • Table 22: Global Prevalence of Diabetes by Gender (2015 & 2040): Number of Adults Diagnosed with Diabetes (in Million) for Men and Women (includes corresponding Graph/Chart)
    • Table 23: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart)
  • Rising Number of Premature Births Enhances Need for Parenteral Nutrition
  • Preterm Birth Statistics from WHO
    • Table 24: Percentage of Preterm Births by Region: 2012 (includes corresponding Graph/Chart)
    • Table 25: Top Ten Countries with the Highest Number of Preterm Births (2012) (includes corresponding Graph/Chart)
    • Table 26: Top Ten Countries with the Highest Rates of Preterm Births (per 100 Live Births): 2012 (includes corresponding Graph/Chart)
  • Inadequate Physiological Development Raises Need for Tube Feeding in Infants
  • Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common Practice
  • Intravenous Therapy in Outpatient Settings to Boost Parenteral Nutrition Market
  • Growing Demand for Home Intravenous Nutritional Therapies
  • Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
  • Pre-mixed IV Nutrition: A Step towards Safer Medication Practices
  • Growing Demand for Low-Cost Parenteral Nutrition Solutions
  • Rising Popularity of Intravenous Vitamin C for Cancer Treatment
  • Increasing Demand for Peripheral Intravenous Nutrition
  • Iron Replacement Therapies - A Potential Market Segment
  • Popularity of TPN as Beauty Treatment Raises Ethical and Safety Concerns
  • Pharmaceutical Industry Participants Migrate from Concentrated Vials to Premixed Solutions
  • Vial Dilution and Potential Risks
  • Premixed Bags Present Efficient Delivery System
  • Switching from Vials to Premixed Bags
  • Challenges Confronting Production of Parenteral Products
  • Continuous Supply of Raw Material: Crucial for Production
  • Rising Preference for Enteral Nutrition: A Threat to Parenteral Nutrition Market
  • Infection Control: A Prime Concern in Parenteral Nutrition
  • Limiting Medication Errors - A Key Concern

3. PRODUCT OVERVIEW

  • Intravenous Solutions - An Insight
  • Intravenous Therapy
  • Intravenous Solutions
    • Tonicity and Osmolality
    • Production of IV Solutions
  • Types of IV Solutions
    • Colloid Solutions
    • Crystalloid Solutions
      • Properties of IV Solution Type Based on Concentration
      • Isotonic Crystalloids
      • Hypertonic Crystalloids
      • Hypotonic Crystalloids
    • Commonly Used Crystalloid Solutions
      • Saline Solution
      • Normal Saline
      • Half-Normal Saline
      • Quarter-Normal Saline
      • Hypertonic Saline
      • Dextrose
      • Saline with Additional Ingredients
      • Intravenous Sugar Solution
      • Dextrose Solutions or D5W
      • Other Types
    • Pre-mixed IV Solutions
    • Large and Small Volume Intravenous Solutions
    • Devices Used in IV Solutions Administration
  • Types of Intravenous Access Devices
    • Peripheral Cannula
    • Central IV Lines
    • Implantable Ports
    • Tunneled Lines
    • Peripherally Inserted Central Catheter (PICC)
  • IV Fluid Packaging
  • Possible Risks in Intravenous Therapy
    • Embolism
    • Electrolyte Imbalance
    • Extravasation/Infiltration
    • Phlebitis
    • Infection
  • Parenteral Nutrition - An Overview
  • An Introduction
  • Parenteral Nutrition Therapy
    • Sources of Parenteral Solutions
  • Routes of Administration
  • Types of Parenteral Nutrition Solutions
    • Total Parenteral Nutrition (TPN)
      • Daily Requirements for Total Parenteral Nutrition (TPN) in Adults
      • Daily Recommended Parenteral Nutritional Intakes for Newborns
    • Partial Parenteral Nutrition (PPN)
    • Home Parenteral Nutrition
  • Central and Peripheral Parenteral Nutrition
  • Inpatient and Outpatient Environments
  • Parenteral Nutrition Formulations
    • Standard Solutions
      • Three-in-One Standard Bags
      • Two-in-one Standard Bags
      • Individual Solutions
      • Non-Standard Solutions
  • Classification of Parenteral Nutrition by Type of Nutrients
    • Amino Acids
    • Carbohydrates
    • Lipids
    • Minerals & Electrolytes
    • Micronutrients
    • Vitamins
    • Trace Elements
  • Large and Small Volume Parenteral Solutions
    • Large Volume Parenteral (LVP) Solutions
    • Small Volume Parenteral (SVP) Solutions
  • IV Fat Emulsions - Enabling Maintenance of Bodyweight
  • Regulatory Prerequisites

4. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Baxter Introduces OLIMEL Emulsion for Parenteral Nutrition
  • Baxter Introduces NUMETA G13%E Preterm 300 mL for Preterm New-borns
  • B. Braun Unveils Parenteral Nutrition 360 (PN360) Program
  • Baxter Introduces NUMETA G13E 300 mL in Europe
  • Fresenius Kabi Introduces Smoflipid Intravenous Fat Emulsion
  • Amanta Healthcare Introduces SteriPort IV Fluid System
  • B. Braun Medical Unveils Clinical Nutrition 360

5. RECENT INDUSTRY ACTIVITY

  • Otsuka OPV to Build New Factory for Distribution of IV Solutions
  • ASPEN Collaborates with Baxter for PN Therapy
  • Grifols Gains FDA Clearance for Physiological Saline Solution
  • Otsuka to Acquire Complete Stake in Otsuka Pharmaceutical India
  • ICU Medical Takes Over Hospira Infusion Systems Business from Pfizer
  • Baxter Acquires Claris Injectables
  • Amanta Healthcare Invests for Development of SteriPort
  • Pfizer Acquires Hospira
  • Baxter and Laboratoire Aguettant Collaborate for PN Trace Elements
  • Actavis Takes Over Allergan

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Allergan plc (Ireland)
  • Amanta Healthcare Ltd (India)
  • B. Braun Melsungen AG (Germany)
  • Baxter International, Inc. (USA)
  • Fresenius KABI AG (Germany)
  • Grifols International S.A. (Spain)
  • ICU Medical, Inc. (USA)
  • Otsuka Pharmaceutical Factory, Inc. (Japan)
  • Sichuan Kelun Pharmaceutical Co., Ltd. (China)
  • Sino-Swed Pharmaceutical Corp. Ltd. (China)

7. GLOBAL MARKET PERSPECTIVE

    • Table 27: World Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for Parenteral Nutrition by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 29: World 14-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America Markets for the Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Market Overview
    • Aging Population Fuels Need for Parenteral Nutrition Solutions
    • Table 30: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Rising Incidences of Chronic Diseases Heightens Need for Clinical Nutrition Products
      • Cancer Statistics in the US
    • Table 31: Estimated Number of New Cancer Cases in the US by State for 2017 (includes corresponding Graph/Chart)
    • Table 32: Estimated Number of New Cancer Cases in the US by Gender and Affected Site for 2017 (includes corresponding Graph/Chart)
    • Table 33: Estimated Number of Cancer-Related Deaths in the US by Gender and Body Site for 2017 (includes corresponding Graph/Chart)
    • Prevalence of Diabetes Mellitus in the US - A Case for Parenteral Nutrition
    • Table 34: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 35: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) (includes corresponding Graph/Chart)
    • Parenteral Nutrition - Vital for Preterm Infants
    • Table 36: Preterm Birth Rate (%) in the US by State for 2015
    • Table 37: Preterm Birth Rate (%) in the US by Race/Ethnicity for 2014 and 2015 (includes corresponding Graph/Chart)
    • Table 38: Preterm Birth Rate (%) in the US by Gestational Age for 2014 and 2015 (includes corresponding Graph/Chart)
    • Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
      • Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
    • Medicare Coverage for Parenteral Nutrition Therapy
      • Reimbursement Regulations to Hamper Market Growth
      • A.S.P.E.N. Practice Guidelines for Parenteral Nutrition
      • A.S.P.E.N. Guidelines for Parenteral Nutrition (as of 2004)
    • Product Launches
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 39: US Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 40: US Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Rising Incidence of Cancer - A Business Case for Parenteral Nutrition Market
    • Table 41: New Cancer Cases (in Thousands) in Canada by Gender for 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 42: Age-Standardized Incidence Rate (Per '000 People) in Canada by Gender and Type of Cancer - 2016 (includes corresponding Graph/Chart)
    • Table 43: New Cancer Cases in Canada by Gender and Affected Site for 2016 (includes corresponding Graph/Chart)
    • Table 44: New Cancer Cases in Canada by Province for 2016 (includes corresponding Graph/Chart)
    • Table 45: New Cancer Cases in Canada by Age Group for 2016 (includes corresponding Graph/Chart)
    • Table 46: Cancer Related Deaths in Canada by Gender and Affected Site for 2016 (includes corresponding Graph/Chart)
    • Table 47: Cancer Related Deaths in Canada by Age Group for 2016 (includes corresponding Graph/Chart)
    • Diabetes Leads to Increase in GI Disorder Cases - Opportunity for PN
    • Table 48: Diabetes Statistics in Canada (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) (includes corresponding Graph/Chart)
    • Product Launch
  • B. Market Analytics
    • Table 49: Canadian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 50: Canadian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Rising Cancer and Diabetes Cases Provide Growth Opportunity
    • Table 51: Cancer Incidence and Number of Cancer-Related Deaths among Japanese Men and Women for 2015 (includes corresponding Graph/Chart)
    • Table 52: Diabetes Statistics in Japan (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and Number of Children with Type 1 diabetes (in '000s) (includes corresponding Graph/Chart)
    • Otsuka Pharmaceutical Factory, Inc. - A Major Player
  • B. Market Analytics
    • Table 53: Japanese Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 54: Japanese Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Aging Population & Rising Incidence of Chronic Diseases to Drive Growth
      • Aging Statistics
    • Table 55: Aging Population in Europe by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Table 56: Aging Population in Europe by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
      • Cancer Trends
    • Table 57: Number of New Cancer Cases in Europe (2012-2030) (in Million) (includes corresponding Graph/Chart)
      • Diabetes Statistics
    • Table 58: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 59: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Product Launch
  • B. Market Analytics
    • Table 60: European Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 61: European Historic Review for Parenteral Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 62: European 14-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for the Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 63: French Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 64: French Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Select Players
  • B. Market Analytics
    • Table 65: German Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 66: German Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 67: Italian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 68: Italian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Product Launch
  • B. Market Analytics
    • Table 69: UK Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 70: UK Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Outlook
    • Grifols International S.A. - A Key Player
  • B. Market Analytics
    • Table 71: Spanish Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 72: Spanish Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 73: Russian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 74: Russian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Allergan plc (Ireland) - A Key Player
  • B. Market Analytics
    • Table 75: Rest of European Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 76: Rest of European Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Market Overview
    • Rising Diabetes Prevalence in Asia-Pacific - Opportunity for PN Market
    • Table 77: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 78: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 79: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 80: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries HIV Statistics in Asia-Pacific (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 81: Asia-Pacific Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - Australia, China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 82: Asia-Pacific Historic Review for Parenteral Nutrition by Geographic Region - Australia, China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 83: Asia-Pacific 14-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Australia, China, India and Rest of Asia-Pacific Markets for the Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

5a. AUSTRALIA

  • Market Analysis
    • Table 84: Australian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 85: Australian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

5b. CHINA

  • A. Market Analysis
    • Outlook
    • Select Players
  • B. Market Analytics
    • Table 86: Chinese Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 87: Chinese Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

5c. INDIA

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Developments
    • Amanta Healthcare Ltd - A Key Player
  • B. Market Analytics
    • Table 88: Indian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 89: Indian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

5d. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 90: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 91: Rest of Asia-Pacific Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA

  • A. Market Analysis
    • Increasing Incidence of Chronic Conditions: Opportunity for PN Market
    • Diabetes Prevalence Statistics
    • Table 92: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 93: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 94: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 95: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 96: Middle East & Africa Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 97: Middle East & Africa Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Rising Incidence of Diabetes in Latin America - Opportunity Indicator
    • Table 98: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 99: Latin American Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 100: Latin American Historic Review for Parenteral Nutrition by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 101: Latin American 14-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Brazil, Mexico and Rest of Latin America Markets for the Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)
Back to Top